ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Cavenee Is President-elect of AACR; Coffey To Succeed Strong As President

April 11, 1997

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

Solomon Gard’s Questions/Answers

January 2, 1981

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Bristol-Myers Nominations Open

August 10, 1979

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003